Removed shunt valves: Reasons for failure and implications for valve design

British Journal of Neurosurgery

Volumn 10, Issue 3, 1996, Pages 245-252

  Brydon, H L ^a,c   Bayston, R ^b   Hayward, R ^a   Harkness, W ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cerebrospinal fluid shunts; Hydrocephalus; Overdrainage; Shunt infection

Indexed keywords

ARTICLE; HUMAN; HYDROCEPHALUS; PRESSURE MEASUREMENT; PRIORITY JOURNAL; SHUNT INFECTION; SHUNTING; SURGICAL EQUIPMENT;

EID: 0029940323     PISSN: 02688697     EISSN: None     Source Type: Journal    
DOI: 10.1080/02688699650040098     Document Type: Article

References (28)

1. Pople IK, Quinn MW, Bayston R. Morbidity and outcome of shunted hydrocephalus. Zeitschr Kinderchir 1990;45, Suppl. 1:29-31
2. Fouyas JP, Casey ATH, Thompson P, Harkness WF, Hayward RD. Use of intracranial pressure monitoring in the management of childhood hydrocephalus and shunt-related problems. Neurosurgery 1996;38:726-32.
3. Rayport MR, Reiss J. Hydrodynamic properties of certain shunt assemblies for the treatment of hydrocephalus. Part 1: report of a case of communicating hydrocephalus with increased cerebrospinal fluid production treated by duplication of shunting devise. Part 2: pressure-flow characteristics of the Spitz-Holter, Pudenz-Heyer and Cordis-Hakim shunt systems. J Neurosurg 1969;30:455-67.
4. Aschoff A, Krämer P, Benesch C, Fruh K, Klank A, Kunza S. Overdrainage and shunt technology: a critical comparison of programmable, hydrostatic and variable resistance valves and flow reducing devices. Child's Nerv Syst 1995;11:193-202.
5. Trost HA, Heissler HE, Claussen G, Gabb MR. Testing the hydrocephalus shunt valve; long term bench test results of various new and explanted valves. The need for a model for testing valves under physiological conditions. Eur J Pediatr Surg 1991;1, Suppl. 1:38-40.
6. Puca A, Anile C, Maria G, Rossi G. Cerebrospinal fluid shunting for hydrocephalus in the adult: factors related to shunt revision. Neurosurgery 1991;822-6.
7. Illingworth RD, Logue V, Symon L. Uemura K. The ventriculocaval shunt in the treatment of adult hydrocephalus. Results and complications in 101 patients. J Neurosurg 1971;35:681-5.
8. Bayston R, Rodgers J. Production of extracellular slime by Staphylococcus epidermidis during stationary phase of growth: its association with adherence to implantable devises. J Clin Pathol 1995;43:866-70.
9. Ludwicka A, Jansen B, Wadström T, Pulverer G. Attachment of staphylococci to various synthetic polymers. Zentralbl Bakteriol Mikrobiol Hyg (A) 1984;256:479-89.
10. Connolly B, Guinney EJ, Fitzgerald RJ. CSF/shunt infections - the bane of our lives! Zeitschr Kinderchir 1987;42, Suppl. 1:13-14.
11. James HE, Walsh JW, Wilson HD, Connor JD, Bean MD, Tibbs PA. Prospective randomised study of therapy in cerebrospinal fluid shunt infections. Neurosurgery 1980;7:459-63.
12. McCullough DC. Symptomatic progressive ventriculomegaly in hydrocephalics with patent shunts and anti-syphon devices. Neurosurgery 1986;19:617-21.
13. Brown EM, Jones EM. Non-surgical management of CSF shunt infections. Eur J Pediatr Surg 1995;5, Suppl. 1:26.
14. Sears FW, Zemansky MW, Young HD. University Physics, 6th edn. Massachusetts, USA, Addison-Wesley Publishing Co., 1982.
15. Brydon HL, Hayward R, Harkness W, Bayston R. Physical properties of cerebrospinal fluid of relevance to shunt function. 2: The effect of protein upon CSF surface tension & contact angle. Br J Neurosurg 1995;9:645-52.
16. Brydon HL, Hayward R, Harkness W, Bayston R. The effect of increasing CSF protein concentration upon shunt function. Eur J Pediatr Surg 1993;3, Suppl. 1:33-4.
17. Hakim S, de la Roche FD, Burton JD. A critical analysis of valve shunts used in the treatment of hydrocephalus. Dev Med Child Neurol 1973;15:230-55.
18. Hakim S. Observations on the physiopathology of the CSF pulse and prevention of ventricular catheter obstruction in valve shunts. Dev Med Child Neurol 1969;11, Suppl. 20:42-8.
19. Little JR, Rhoton AL, Mellinger JF. Comparison of ventriculoperitoneal and ventriculoatrial shunts for hydrocephalus in children. Mayo Clin Proc 1972;47:396-401.
20. Sekhar LM, Moossy J, Guthkelch AN. Malfunctioning ventriculoperitoneal shunts. Clinical and pathological features. J Neurosurg 1982;56:411-16.
21. Anderson M, Matthews KB, Stuart J. Coagulation and fibrinolytic activity of cerebrospinal fluid. J Clin Pathol 1978;31:488-92.
22. Dube RK, Sahaa PK, Dude B, Katiyar BC, Rao PVB. Fibrinogen, fibrinogen degradation products and fibrinolytic activity in cerebrospinal fluid in stroke. Ind J Med Res 1980;72:454-7.
23. Snow RB, Kossovsky N. Hypersensitivity reaction associated with sterile ventriculoperitoneal shunt malfunction. Surg Neurol 1989;31:209-214.
24. Echizenya K, Satoh M, Murai H, Ueno H, Abe H, Komai T. Mineralisation and biodegradation of CSF shunting systems. J Neurosurg 1987;67:584-91.
25. Serlo W, Saukkonen AL, Heikkinen E, von Wendt L. The incidence and management of the slit ventricle syndrome. Acta Neurochir (Wien) 1989;99:113-16.
26. Jaskolska E, MacKinnon AE. Experiences with the anti-siphon devices: successes and complications. Zeitschr Kinderchir 1988;43, Suppl. 2:22-3.
27. Portnoy HD, Schulte RR, Fox JL, Croissant PD, Tripp L. Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural haematomas. J Neurosurg 1973;38:729-38.
28. Dietrich U, Lumenta C, Sprick C, Majewski B. Subdural hematoma in case of hydrocephalus and macrocrania. Experience with a pressure-adjustable valve. Childs Nerv Syst 1987;3:242-3.